Stenotrophomonas maltophilia biofilm: its role in infectious diseases

References

• Looney WJ. Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br J Biomed Sci. 2005;62(3):145–154; quiz 1 p following 54.
   PubMed Web of Science ®Google Scholar
• Nyc O, Matejkova J. Stenotrophomonas maltophilia: significant contemporary hospital pathogen - review. Folia Microbiol (Praha). 2010;55(3):286–294.
   PubMed Web of Science ®Google Scholar
• Chang YT, Lin CY, Chen YH, et al. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893.
   PubMed Web of Science ®Google Scholar
• Adegoke AA, Stenstrom TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8:2276.
   PubMed Web of Science ®Google Scholar
• Brooke JS. New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev Anti Infect Ther. 2014;12(1):1–4.
   PubMed Web of Science ®Google Scholar
• Huedo P, Coves X, Daura X, et al. Quorum sensing signaling and quenching in the multidrug-resistant pathogen Stenotrophomonas maltophilia. Front Cell Infect Microbiol. 2018;8:122.
   PubMed Web of Science ®Google Scholar
• Trifonova A, Strateva T. Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. Infect Dis (Lond). 2019;51(3):168–178.
   PubMed Web of Science ®Google Scholar
• Kalidasan V, Joseph N, Kumar S, et al. Iron and virulence in Stenotrophomonas maltophilia: all we know so far. Front Cell Infect Microbiol. 2018;8:401.
   PubMed Web of Science ®Google Scholar
• Gales AC, Seifert H, Gur D, et al. Antimicrobial susceptibility of acinetobacter calcoaceticus-acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997–2016). Open Forum Infect Dis. 2019;6(Suppl 1):S34–S46.
   PubMed Web of Science ®Google Scholar
• Willsey GG, Eckstrom K, LaBauve AE, et al. Stenotrophomonas maltophilia differential gene expression in synthetic cystic fibrosis sputum reveals shared and cystic fibrosis strain-specific responses to the sputum environment. J Bacteriol. 2019;201 (15) e00074–19.
   Web of Science ®Google Scholar
• World Health Organization. Public health importance of antimicrobial resistance. 2019 May 30.
   Google Scholar
• Zhanel GG, Golden AR, Zelenitsky S, et al. Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative bacilli. Drugs. 2019;79(3):271–289.
   PubMed Web of Science ®Google Scholar
• Lin YT, Huang YW, Liou RS, et al. MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation. J Antimicrob Chemother. 2014;69(12):3221–3226.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, Verginelli F, et al. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression. FEMS Microbiol Lett. 2016;363(14). pii: fnw145.
   PubMed Web of Science ®Google Scholar
• McKay GA, Woods DE, MacDonald KL, et al. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun. 2003;71(6):3068–3075.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Pomponio S, Crocetta V, et al. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC Microbiol. 2011;11:159.
   PubMed Web of Science ®Google Scholar
• Zhuo C, Zhao QY, Xiao SN. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. PLoS One. 2014;9(10):e108409.
   PubMed Web of Science ®Google Scholar
• Madi H, Lukic J, Vasiljevic Z, et al. Genotypic and phenotypic characterization of Stenotrophomonas maltophilia strains from a pediatric tertiary care hospital in Serbia. PLoS One. 2016;11(10):e0165660.
   PubMed Web of Science ®Google Scholar
• Bostanghadiri N, Ghalavand Z, Fallah F, et al. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol. 2019;10:1191.
   PubMed Web of Science ®Google Scholar
• Huang TP, Somers EB, Wong AC. Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia. J Bacteriol. 2006;188(8):3116–3120.
   PubMed Web of Science ®Google Scholar
• de Oliveira-garcia D, Dall’Agnol M, Rosales M, et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol. 2003;5(9):625–636.
   PubMed Web of Science ®Google Scholar
• Crossman LC, Gould VC, Dow JM, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9(4):R74.
   PubMed Web of Science ®Google Scholar
• Gallo SW, Figueiredo TP, Bessa MC, et al. Isolation and characterization of Stenotrophomonas maltophilia isolates from a Brazilian hospital. Microb Drug Resist. 2016;22(8):688–695.
   PubMed Web of Science ®Google Scholar
• Nicoletti M, Iacobino A, Prosseda G, et al. Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol. 2011;301(1):34–43.
   PubMed Web of Science ®Google Scholar
• Ryan RP, Monchy S, Cardinale M, et al. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol. 2009;7(7):514–525.
   PubMed Web of Science ®Google Scholar
• de Oliveira-garcia D, Dall’Agnol M, Rosales M, et al. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg Infect Dis. 2002;8(9):918–923.
   PubMed Web of Science ®Google Scholar
• Kang XM, Wang FF, Zhang H, et al. Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulator. Appl Environ Microbiol. 2015;81(4):1200–1209.
   PubMed Web of Science ®Google Scholar
• Liu W, Tian XQ, Wei JW, et al. BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia. Sci Rep. 2017;7(1):4665.
   PubMedGoogle Scholar
• Di Bonaventura G, Prosseda G, Del Chierico F, et al. Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol. 2007;20(3):529–537.
   PubMed Web of Science ®Google Scholar
• Roscetto E, Angrisano T, Costa V, et al. Functional characterization of the RNA chaperone Hfq in the opportunistic human pathogen Stenotrophomonas maltophilia. J Bacteriol. 2012;194(21):5864–5874.
   PubMed Web of Science ®Google Scholar
• Yang JG, Shih MS, Kuo WT, et al. Crystallization of the N-terminal regulatory domain of the enhancer-binding protein FleQ from Stenotrophomonas maltophilia. Acta Crystallogr F Struct Biol Commun. 2014;70(Pt 3):326–330.
   PubMedGoogle Scholar
• Lin YT, Huang YW, Chen SJ, et al. The SmeYZ efflux pump of Stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice. Antimicrob Agents Chemother. 2015;59(7):4067–4073.
   PubMed Web of Science ®Google Scholar
• Burmolle M, Ren D, Bjarnsholt T, et al. Interactions in multispecies biofilms: do they actually matter? Trends Microbiol. 2014;22(2):84–91.
   PubMed Web of Science ®Google Scholar
• Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol Lett. 2004;236(2):163–173.
   PubMed Web of Science ®Google Scholar
• Sharahi JY, Azimi T, Shariati A, et al. Advanced strategies for combating bacterial biofilms. J Cell Physiol. 2019;234:14689–14708.
   Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193.
   PubMed Web of Science ®Google Scholar
• Hoiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011;3(2):55–65.
   PubMed Web of Science ®Google Scholar
• Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061–1072.
   PubMed Web of Science ®Google Scholar
• Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis. 2015;34(5):877–886.
   PubMed Web of Science ®Google Scholar
• An SQ, Tang JL. Diffusible signal factor signaling regulates multiple functions in the opportunistic pathogen Stenotrophomonas maltophilia. BMC Res Notes. 2018;11(1):569.
   PubMedGoogle Scholar
• Ryan RP, Fouhy Y, Garcia BF, et al. Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in pseudomonas aeruginosa. Mol Microbiol. 2008;68(1):75–86.
   PubMed Web of Science ®Google Scholar
• An SQ, Berg G. Stenotrophomonas maltophilia. Trends Microbiol. 2018;26(7):637–638.
   PubMed Web of Science ®Google Scholar
• Ryan RP, An SQ, Allan JH, et al. The DSF family of cell-cell signals: an expanding class of bacterial virulence regulators. PLoS Pathog. 2015;11(7):e1004986.
   PubMed Web of Science ®Google Scholar
• Fouhy Y, Scanlon K, Schouest K, et al. Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol. 2007;189(13):4964–4968.
   PubMed Web of Science ®Google Scholar
• Fouhy Y, Scanlon K, Schouest K, et al.; Retraction for Fouhy et al., Diffusible signal factor-dependent cell-cell signaling and virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol. 2018;200(12). pii: e00235–18.
   PubMed Web of Science ®Google Scholar
• Alcaraz E, Garcia C, Friedman L, et al. The rpf/DSF signalling system of Stenotrophomonas maltophilia positively regulates biofilm formation, production of virulence-associated factors and beta-lactamase induction. FEMS Microbiol Lett. 2019;366(6). pii: fnz069.
   PubMed Web of Science ®Google Scholar
• Garcia CA, Alcaraz ES, Franco MA. Passerini de Rossi BN. Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence. Front Microbiol. 2015;6:926.
   PubMed Web of Science ®Google Scholar
• Huedo P, Yero D, Martinez-Servat S, et al. Two different rpf clusters distributed among a population of Stenotrophomonas maltophilia clinical strains display differential diffusible signal factor production and virulence regulation. J Bacteriol. 2014;196(13):2431–2442.
   PubMed Web of Science ®Google Scholar
• Huedo P, Yero D, Martinez-Servat S, et al. Decoding the genetic and functional diversity of the DSF quorum-sensing system in Stenotrophomonas maltophilia. Front Microbiol. 2015;6:761.
   PubMedGoogle Scholar
• Zheng L, Wang FF, Ren BZ, et al. Systematic mutational analysis of histidine kinase genes in the nosocomial pathogen Stenotrophomonas maltophilia Identifies BfmAK system control of biofilm development. Appl Environ Microbiol. 2016;82(8):2444–2456.
   PubMed Web of Science ®Google Scholar
• Lee SW, Han SW, Sririyanum M, et al. A type I-secreted, sulfated peptide triggers XA21-mediated innate immunity. Science. 2009;326(5954):850–853.
   PubMed Web of Science ®Google Scholar
• McCarthy Y, Dow JM, Ryan RP. The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol. 2011;193(22):6375–6378.
   PubMed Web of Science ®Google Scholar
• Han SW, Sriariyanun M, Lee SW, et al. Small protein-mediated quorum sensing in a Gram-negative bacterium. PLoS One. 2011;6(12):e29192.
   PubMed Web of Science ®Google Scholar
• Lee SW, Han SW, Sririyanum M, et al. Retraction. A type I-secreted, sulfated peptide triggers XA21-mediated innate immunity. Science. 2013;342(6155):191.
   PubMed Web of Science ®Google Scholar
• Retraction: Small protein-mediated quorum sensing in a gram-negative bacterium. PLoS One. 2013;8(9). DOI: 10.1371/annotation/880a72e1-9cf3-45a9-bf1c-c74ccb73fd35.
   Google Scholar
• McCarthy Y, Dow JM, Ryan RP. Retraction for McCarthy et al., The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J Bacteriol. 2017;199(10). pii: e00156–17.
   PubMed Web of Science ®Google Scholar
• Bahar O, Pruitt R, Luu DD, et al. The Xanthomonas Ax21 protein is processed by the general secretory system and is secreted in association with outer membrane vesicles. PeerJ. 2014;2:e242.
   PubMed Web of Science ®Google Scholar
• Devos S, Van Oudenhove L, Stremersch S, et al. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front Microbiol. 2015;6:298.
   PubMed Web of Science ®Google Scholar
• An SQ, Tang JL. The Ax21 protein influences virulence and biofilm formation in Stenotrophomonas maltophilia. Arch Microbiol. 2018;200(1):183–187.
   PubMed Web of Science ®Google Scholar
• Martinez P, Huedo P, Martinez-Servat S, et al. Stenotrophomonas maltophilia responds to exogenous AHL signals through the LuxR solo SmoR (Smlt1839). Front Cell Infect Microbiol. 2015;5:41.
   PubMed Web of Science ®Google Scholar
• Jucker BA, Harms H, Zehnder AJ. Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon. J Bacteriol. 1996;178(18):5472–5479.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, Confalone P, et al. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 2010;10:102.
   PubMed Web of Science ®Google Scholar
• Zgair AK, Chhibber S. Adhesion of Stenotrophomonas maltophilia to mouse tracheal mucus is mediated through flagella. J Med Microbiol. 2011;60(Pt 7):1032–1037.
   PubMed Web of Science ®Google Scholar
• Zgair AK, Ghafil JA, Radif HM, et al. Moxifloxacin reduces Stenotrophomonas maltophilia adhesion to mouse intestinal tract in vitro. Pak J Pharm Sci. 2017;30(5):1753–1757.
   PubMed Web of Science ®Google Scholar
• De Vidipo LA, De Marques EA, Puchelle E, et al. Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro. Microbiol Immunol. 2001;45(8):563–569.
   PubMed Web of Science ®Google Scholar
• Tan CK, Liaw SJ, Yu CJ, et al. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis. 2008;60(2):205–210.
   PubMed Web of Science ®Google Scholar
• Alcaraz E, Garcia C, Papalia M, et al. Stenotrophomonas maltophilia isolated from patients exposed to invasive devices in a university hospital in Argentina: molecular typing, susceptibility and detection of potential virulence factors. J Med Microbiol. 2018;67:992–1002.
   Web of Science ®Google Scholar
• Flores-Trevino S, Gutierrez-Ferman JL, Morfin-Otero R, et al. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity. J Med Microbiol. 2014;63(Pt 11):1524–1530.
   PubMedGoogle Scholar
• Steinmann J, Mamat U, Abda EM, et al. Analysis of phylogenetic variation of Stenotrophomonas maltophilia reveals human-specific branches. Front Microbiol. 2018;9:806.
   PubMed Web of Science ®Google Scholar
• Roy R, Tiwari M, Donelli G, et al. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522–554.
   PubMed Web of Science ®Google Scholar
• Waharte F, Steenkeste K, Briandet R, et al. Diffusion measurements inside biofilms by image-based fluorescence recovery after photobleaching (FRAP) analysis with a commercial confocal laser scanning microscope. Appl Environ Microbiol. 2010;76(17):5860–5869.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Piccolomini R, Picciani C, et al. Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. FEMS Microbiol Lett. 2008;287(1):41–47.
   PubMed Web of Science ®Google Scholar
• Passerini de Rossi B, Calenda M, Vay C, et al. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol. 2007;39(4):204–212.
   PubMedGoogle Scholar
• Cescutti P, Cuzzi B, Liut G, et al. A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis. Carbohydr Res. 2011;346(13):1916–1923.
   PubMed Web of Science ®Google Scholar
• Keegan R, Waterman DG, Hopper DJ, et al. The 1.1 A resolution structure of a periplasmic phosphate-binding protein from Stenotrophomonas maltophilia: a crystallization contaminant identified by molecular replacement using the entire protein data bank. Acta Crystallogr D Struct Biol. 2016;72(Pt 8):933–943.
   PubMedGoogle Scholar
• Di Bonaventura G, Stepanovic S, Picciani C, et al. Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates. Folia Microbiol (Praha). 2007;52(1):86–90.
   PubMed Web of Science ®Google Scholar
• Zgair AK, Chhibber S. Adhering ability of Stenotrophomonas maltophilia is dependent on growth conditions. Mikrobiologiia. 2011;80(4):459–464.
   PubMedGoogle Scholar
• Biocanin M, Madi H, Vasiljevic Z, et al. Temperature, pH and trimethoprim-sulfamethoxazole are potent inhibitors of biofilm formation by Stenotrophomonas maltophilia clinical isolates. Pol J Microbiol. 2017;66(4):433–438.
   PubMed Web of Science ®Google Scholar
• Di Bonaventura G, Spedicato I, D’Antonio D, et al. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother. 2004;48(1):151–160.
   PubMed Web of Science ®Google Scholar
• Wang A, Wang Q, Kudinha T, et al. Effects of Fluoroquinolones and azithromycin on biofilm formation of Stenotrophomonas maltophilia. Sci Rep. 2016;6:29701.
   PubMed Web of Science ®Google Scholar
• Elias S, Banin E. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol Rev. 2012;36(5):990–1004.
   PubMed Web of Science ®Google Scholar
• Burmolle M, Webb JS, Rao D, et al. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol. 2006;72(6):3916–3923.
   PubMed Web of Science ®Google Scholar
• Elvers KT, Leeming K, Lappin-Scott HM. Binary culture biofilm formation by Stenotrophomonas maltophilia and Fusarium oxysporum. J Ind Microbiol Biotechnol. 2001;26(3):178–183.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, De Nicola S, et al. Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. Front Microbiol. 2015;6:951.
   PubMed Web of Science ®Google Scholar
• Melloul E, Luiggi S, Anais L, et al. Characteristics of aspergillus fumigatus in association with Stenotrophomonas maltophilia in an in vitro model of mixed biofilm. PLoS One. 2016;11(11):e0166325.
   PubMed Web of Science ®Google Scholar
• Melloul E, Roisin L, Durieux MF, et al. Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: does the Strain Matter? Front Microbiol. 2018;9:2850.
   PubMed Web of Science ®Google Scholar
• de Rossi BP, Garcia C, Alcaraz E, et al. Stenotrophomonas maltophilia interferes via the DSF-mediated quorum sensing system with Candida albicans filamentation and its planktonic and biofilm modes of growth. Rev Argent Microbiol. 2014;46(4):288–297.
   PubMed Web of Science ®Google Scholar
• Ciofu O, Rojo-Molinero E, Macia MD, et al. Antibiotic treatment of biofilm infections. APMIS. 2017;125(4):304–319.
   PubMed Web of Science ®Google Scholar
• Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018;16(1):51–65.
   PubMed Web of Science ®Google Scholar
• Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41.
   PubMed Web of Science ®Google Scholar
• Ciofu O, Tolker-Nielsen T, Jensen PO, et al. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev. 2015;85:7–23.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, Ghosh D, et al. Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year colonization in the lungs of a cystic fibrosis patient. Front Microbiol. 2016;7:1551.
   PubMed Web of Science ®Google Scholar
• Wu K, Yau YC, Matukas L, et al. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 2013;57(3):1546–1548.
   PubMed Web of Science ®Google Scholar
• Macia MD, Rojo-Molinero E, Oliver A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect. 2014;20(10):981–990.
   PubMed Web of Science ®Google Scholar
• Algburi A, Comito N, Kashtanov D, et al. Control of biofilm formation: antibiotics and beyond. Appl Environ Microbiol. 2017;83(3).pii: e02508–16.
   Web of Science ®Google Scholar
• Di Bonaventura G, Pompilio A, Crocetta V, et al. Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens. Future Microbiol. 2014;9(12):1303–1317.
   PubMed Web of Science ®Google Scholar
• Halstead FD, Thwaite JE, Burt R, et al. Antibacterial activity of blue light against nosocomial wound pathogens growing planktonically and as mature biofilms. Appl Environ Microbiol. 2016;82(13):4006–4016.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Geminiani C, Bosco D, et al. Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens. Front Microbiol. 2018;9:1349.
   PubMed Web of Science ®Google Scholar
• Cremonini E, Zonaro E, Donini M, et al. Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microb Biotechnol. 2016;9(6):758–771.
   PubMed Web of Science ®Google Scholar
• Cremonini E, Boaretti M, Vandecandelaere I, et al. Biogenic selenium nanoparticles synthesized by Stenotrophomonas maltophilia SeITE02 loose antibacterial and antibiofilm efficacy as a result of the progressive alteration of their organic coating layer. Microb Biotechnol. 2018;11(6):1037–1047.
   PubMed Web of Science ®Google Scholar
• Zonaro E, Lampis S, Turner RJ, et al. Biogenic selenium and tellurium nanoparticles synthesized by environmental microbial isolates efficaciously inhibit bacterial planktonic cultures and biofilms. Front Microbiol. 2015;6:584.
   PubMed Web of Science ®Google Scholar
• Gomes IB, Simoes M, Simoes LC. The effects of sodium hypochlorite against selected drinking water-isolated bacteria in planktonic and sessile states. Sci Total Environ. 2016;565:40–48.
   PubMed Web of Science ®Google Scholar
• Pollini S, Di Pilato V, Landini G, et al. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS One. 2018;13(10):e0203941.
   PubMed Web of Science ®Google Scholar
• Kregiel D, Rygala A, Kolesinska B, et al. Antimicrobial and Antibiofilm N-acetyl-L-cysteine grafted siloxane polymers with potential for use in water systems. Int J Mol Sci. 2019;20(8):2011.
   Web of Science ®Google Scholar
• Ciacci N, Boncompagni S, Valzano F, et al. In vitro synergism of colistin and N-acetylcysteine against Stenotrophomonas maltophilia. Antibiotics (Basel). 2019;8(3).pii: E101.
   PubMed Web of Science ®Google Scholar
• Gomes IB, Querido MM, Teixeira JP, et al. Prolonged exposure of Stenotrophomonas maltophilia biofilms to trace levels of clofibric acid alters antimicrobial tolerance and virulence. Chemosphere. 2019;235:327–335.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Crocetta V, Scocchi M, et al. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed alpha-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. BMC Microbiol. 2012;12:145.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Scocchi M, Pomponio S, et al. Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides. 2011;32(9):1807–1814.
   PubMed Web of Science ®Google Scholar
• Karunanidhi A, Thomas R, van Belkum A, et al. In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain. Biomed Res Int. 2013;2013:392058.
   PubMedGoogle Scholar
• Vidigal PG, Musken M, Becker KA, et al. Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm. PLoS One. 2014;9(4):e92876.
   PubMed Web of Science ®Google Scholar
• Karunanidhi A, Ghaznavi-Rad E, Hamat RA, et al. Antibacterial and antibiofilm activities of nonpolar extracts of allium stipitatum regel. against multidrug resistant bacteria. Biomed Res Int. 2018;2018:9845075.
   PubMedGoogle Scholar
• Kim HR, Lee D, Eom YB. Anti-biofilm and anti-virulence efficacy of celastrol against Stenotrophomonas maltophilia. Int J Med Sci. 2018;15(6):617–627.
   PubMed Web of Science ®Google Scholar
• Chanyi RM, Koval SF, Brooke JS. Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus. Environ Microbiol Rep. 2016;8(3):343–351.
   PubMed Web of Science ®Google Scholar
• Minardi D, Montanari MP, Tili E, et al. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents. J Chemother. 2008;20(2):195–201.
   PubMed Web of Science ®Google Scholar
• Passerini de Rossi B, Garcia C, Calenda M, et al. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. Int J Antimicrob Agents. 2009;34(3):260–264.
   PubMed Web of Science ®Google Scholar
• Passerini de Rossi B, Feldman L, Pineda MS, et al. Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms. J Med Microbiol. 2012;61(Pt9):1248–1253.
   PubMedGoogle Scholar
• Sun E, Liang G, Wang L, et al. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms. Braz J Infect Dis. 2016;20(4):365–373.
   PubMed Web of Science ®Google Scholar
• Pompilio A, Catavitello C, Picciani C, et al. Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. J Med Microbiol. 2010;59(Pt 1):76–81.
   PubMed Web of Science ®Google Scholar
• Malinowski AM, McClarty BM, Robinson C, et al. Polysorbate 80 and polymyxin B inhibit Stenotrophomonas maltophilia biofilm. Diagn Microbiol Infect Dis. 2017;87(2):154–156.
   PubMed Web of Science ®Google Scholar